The United Laboratories International Holdings Limited
(Incorporated in the Cayman Islands with limited liability)

Press Releases       

2021-August-27	The United Laboratories International Holdings Limited, Announces 2021 Interim Results, Profit Attributable to Shareholders up by 207.2% to RMB623.1 Million Insulin Series Products Maintained Steady Growth, Successfully Delivered First Batch of Insulin Aspart Products (in PDF)
2021-July-15	TUL Receives Drug Registration Approval for Insulin Aspart, Enriching Portfolio of Diabetic Drugs (in PDF)
2021-March-30	The United Laboratories International Holdings Limited, Announces 2020 Annual Results, Profit attributable to Shareholders up by 9.5% to RMB703 Million, Insulin Series Beat Sales Targets (in PDF)
2024	2024 Press Releases
2023	2023 Press Releases
2022	2022 Press Releases
2020	2020 Press Releases
2019	2019 Press Releases
2018	2018 Press Releases
2017	2017 Press Releases
2016	2016 Press Releases
2015	2015 Press Releases
2014	2014 Press Releases
2013	2013 Press Releases
2012	2012 Press Releases
2011	2011 Press Releases
2010	2010 Press Releases
2009	2009 Press Releases
2008	2008 Press Releases
2007	2007 Press Releases